UniPharma Co., Ltd. announced earnings results for the half year ended June 30, 2020. For the half year, the company announced sales was TWD 69.178 million compared to TWD 74.811 million a year ago. Operating loss was TWD 9.429 million compared to TWD 19.326 million a year ago. Net loss was TWD 6.595 million compared to TWD 17.949 million a year ago. Basic loss per share was TWD 0.19 compared to TWD 0.51 a year ago.